Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 70Triple Negative Breast Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 4Inflammatory Breast Neoplasms 3Seroma 2Ovarian Neoplasms 2Neoplasm Metastasis 2Invasive Breast Cancer 2Carcinoma, Ductal, Breast 2Breast Cancer Invasive 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Sarcoma 1Premenopausal Breast Cancer 1Patient Preference 1Pain, Postoperative 1Pain 1Neoplastic Cells, Circulating 1Neoplasms 1Myofibroma 1Mesothelioma, Malignant 1Lymphatic Metastasis 1Inflammation 1Hereditary Breast and Ovarian Cancer Syndrome 1HER2-positive Early Breast Cancer 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1

Interventions

pyrotinib 2Surgical Procedures, Operative 2pertuzumab 1Trastuzumab 1Neoadjuvant Therapy 1Mastectomy 1Leuprolide 1Goserelin 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Cancer Invasive × Surgical Procedures, Operative × Breast × Clear all
NCT06716073 2024-12-04

Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Recruiting
1,380 enrolled
Breast

Breast Cancer Invasive

NCT04398914 2022-03-31

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Shanghai Jiao Tong University School of Medicine

Phase 2 Active not recruiting
216 enrolled
Breast

Breast Cancer Invasive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡